Cialis is a brand-name prescription tablet containing tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor. It is commonly associated with erectile dysfunction, but its U.S. labeling also includes treatment of signs and symptoms of benign prostatic hyperplasia (BPH) and ED occurring with BPH in eligible patients. These indications involve different clinical assessments; recognizing the brand name is not enough to determine an appropriate regimen.
The Cialis label describes both as-needed and once-daily use for ED. In as-needed treatment, clinical studies observed improvements in erectile function compared with placebo up to 36 hours after a dose, without implying an uninterrupted erection. Once-daily treatment is a separate prescribed plan, and the labeled BPH contexts are not simply an extension of as-needed ED treatment.
This page identifies the branded product, its labeled uses and how it differs from the generic product category. For broader active-ingredient considerations see the tadalafil hub; for the brand dispensing process see how to obtain prescribed Cialis; for a side-by-side product assessment see Cialis versus generic tadalafil.
Tadalafil is the active ingredient; Cialis is a proprietary name attached to a regulated product. The distinction matters because an online page can use a familiar brand in advertising without showing that the seller is offering an authentic U.S.-approved, prescribed product.
Cialis is associated with the Lilly U.S. brand label, but an FDA-approved drug name and a particular dispensed package are separate facts. The pharmacy should verify the approved application, strength and package-level NDC on the real container. A seller's screenshot, similarly named foreign product or generic listing cannot by itself establish that branded Cialis will be supplied.
Cialis has approved labeling for erectile dysfunction, symptoms associated with BPH, and eligible patients with both ED and BPH. ED concerns the erectile response to sexual stimulation, whereas BPH involves urinary symptoms that merit clinical evaluation for other possible causes.
Patients should not infer that all three indications share a single schedule. The ED and BPH guide discusses the overlap, while the ED condition overview addresses broader evaluation rather than brand-specific labeling.
| Labeled context | What it addresses | Distinction |
|---|---|---|
| ED, as needed | Erectile response around sexual activity | Not a regular daily BPH regimen |
| ED, once daily | ED treatment on a consistent schedule | Not timed to each sexual encounter |
| BPH, once daily | Signs and symptoms of BPH | Urinary-condition context |
| ED with BPH, once daily | Both labeled conditions together | Indication-specific clinical decision |
Daily and as-needed describe distinct tadalafil prescribing frameworks rather than competing product grades. The current U.S. branded Cialis labeling discusses 2.5 mg as a starting once-daily ED dose, with a possible clinician-directed adjustment to 5 mg; as-needed ED labeling has a separate framework. BPH and concurrent ED/BPH have specific once-daily labeling and should not be inferred from the brand name alone.
Explore once-daily tadalafil, as-needed tadalafil and the direct regimen comparison. Patients should follow the actual prescription rather than choosing a schedule from an online catalog.
A crucial distinction is between a labeled dose, an FDA-approved tablet strength and a specific branded package currently shown in DailyMed. The referenced U.S. Lilly Cialis brand entry updated in June 2026 lists branded package presentations for 5, 10 and 20 mg tablets, while its dosage section also discusses 2.5 mg once-daily ED treatment. Other tadalafil labels and historical Cialis records list 2.5 mg presentations. None of those facts alone establish that a pharmacy can supply a branded 2.5 mg package today.
The appropriate product and strength follow the prescription. If 2.5 mg daily tadalafil is prescribed, ask the licensed pharmacist which exact approved product and presentation can be dispensed, rather than assuming all historically labeled Cialis strengths remain on the branded shelf. The tadalafil strengths directory catalogs the product strengths, while the dosage overview addresses the clinical context.
The as-needed label reflects measured improvements in erectile function at observations extending up to 36 hours after dosing. It does not describe 36 hours of continuous erection or guarantee the same response in every person. Sexual stimulation remains necessary for the medication to support an erectile response.
For distinctions among taking the tablet, expected response and persistence of effect, read tadalafil onset and the tadalafil duration guide.
When a prescription specifies brand Cialis, ask the dispensing pharmacy to confirm the proprietary name, Lilly-branded label, dosage form, strength and package-specific NDC against the actual item it will dispense. A legitimate branded listing can include several package sizes, and approval or a historical label does not provide a live stock guarantee. If the prescription permits an approved generic, the pharmacist should identify that substitution explicitly.
Tablet appearance and an online photograph are secondary checks, not substitutes for a legitimate dispensing record. A genuine generic tadalafil tablet can look different from branded Cialis, while an unfamiliar imported package may not be U.S.-approved at all. Brand-name supply questions are covered separately by the Cialis buying guide.
FDA-approved generic tadalafil products use the same active ingredient and follow relevant quality and bioequivalence requirements. Their packaging, imprint, inactive ingredients and labeler may differ from Cialis, but those differences are not proof that the approved generic has a weaker clinical effect.
To evaluate those details, see the generic product overview and the brand-versus-generic comparison. Ask the pharmacist what approved product is actually being dispensed.
Before a Cialis prescription, a clinician reviews cardiovascular status, other medicines and medical factors affecting sexual activity. Concomitant use with organic nitrates or riociguat is contraindicated because of serious blood-pressure effects; other interacting medications can also change exposure or tolerability.
An erection lasting longer than four hours is an emergency. Sudden vision or hearing changes require prompt assessment. The ingredient-level safety details are available in tadalafil side effects and tadalafil interactions.
Being an FDA-approved brand does not establish whether a particular product is on a pharmacy shelf or whether a patient is clinically eligible. The prescribing clinician assesses appropriateness, while a licensed pharmacy verifies and dispenses the valid prescription according to relevant law.
For a brand-focused fulfillment workflow use the Cialis prescription purchasing guide. Availability verification and local-pickup questions belong to tadalafil availability and local pharmacy dispensing.
Brand selection, approved generic alternatives, prescribed quantity, pharmacy dispensing arrangements and insurance terms can all influence out-of-pocket cost. A brand-name prescription does not establish a universal pharmacy price or insurance reimbursement, and an advertised listing may omit required fees.
The evergreen tadalafil price guide explains cost variables without volatile totals. Ask a licensed pharmacy to identify the precise branded product and provide a current complete quote before proceeding.
Cialis contains tadalafil, a PDE5 inhibitor used under prescription for the approved labeled indications.
No. U.S. labeling includes ED, BPH symptoms and ED with BPH in eligible patients.
Yes, tadalafil has an approved once-daily framework for certain indications; the prescriber selects the appropriate regimen.
No. Cialis is a brand; generic tadalafil refers to separately approved or authorized U.S. product categories.
No. The studied as-needed response window is not a continuous erection, and sexual stimulation is required.
No. The current referenced Lilly brand package listing and historical tadalafil strength labels are not identical, and neither demonstrates local inventory. Ask a licensed pharmacy to verify the exact brand, strength and package.
No. Concomitant organic nitrate therapy is contraindicated because of a potentially dangerous blood-pressure drop.
Through a licensed pharmacy dispensing a valid prescription after an appropriate clinical evaluation, subject to product availability.